Centessa Pharmaceuticals’ Presentation of New 18-Month Data from Open-Label Extension (OLE) of Phase 2a Study of SerpinPC for Hemophilia Dec 10, 2022 Click here for Webcast Supporting Materials Data Readout: Open-Label Extension (OLE) of Phase 2a Study of SerpinPC for Hemophilia 1.5 MB
